NCT02144701View on ClinicalTrials.gov

Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 18, 2013

Primary Completion Date

February 28, 2016

Study Completion Date

February 28, 2018

Conditions
Graft Versus Host Disease
Interventions
DIETARY_SUPPLEMENT

Lactobacillus rhamnosus GG

Given PO

OTHER

laboratory biomarker analysis was not performed because of no differences in the clinical outcomes

Correlative studies

Trial Locations (1)

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Rutgers, The State University of New Jersey

OTHER

NCT02144701 - Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter